DE69019359D1 - Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen. - Google Patents

Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.

Info

Publication number
DE69019359D1
DE69019359D1 DE69019359T DE69019359T DE69019359D1 DE 69019359 D1 DE69019359 D1 DE 69019359D1 DE 69019359 T DE69019359 T DE 69019359T DE 69019359 T DE69019359 T DE 69019359T DE 69019359 D1 DE69019359 D1 DE 69019359D1
Authority
DE
Germany
Prior art keywords
proteins
particles
virus
vaccines
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69019359T
Other languages
English (en)
Other versions
DE69019359T2 (de
DE69019359T3 (de
Inventor
Caroline Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Leiden
Original Assignee
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19855310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69019359(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Universiteit Leiden filed Critical Universiteit Leiden
Publication of DE69019359D1 publication Critical patent/DE69019359D1/de
Publication of DE69019359T2 publication Critical patent/DE69019359T2/de
Application granted granted Critical
Publication of DE69019359T3 publication Critical patent/DE69019359T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14323Virus like particles [VLP]
DE69019359T 1989-09-14 1990-09-11 Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen. Expired - Lifetime DE69019359T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL8902301 1989-09-14
NL8902301A NL8902301A (nl) 1989-09-14 1989-09-14 Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.
PCT/NL1990/000130 WO1991004330A1 (en) 1989-09-14 1990-09-11 Human parvovirus b19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines

Publications (3)

Publication Number Publication Date
DE69019359D1 true DE69019359D1 (de) 1995-06-14
DE69019359T2 DE69019359T2 (de) 1995-10-12
DE69019359T3 DE69019359T3 (de) 2006-09-07

Family

ID=19855310

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019359T Expired - Lifetime DE69019359T3 (de) 1989-09-14 1990-09-11 Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.

Country Status (7)

Country Link
EP (1) EP0491824B2 (de)
AT (1) ATE122395T1 (de)
DE (1) DE69019359T3 (de)
DK (1) DK0491824T4 (de)
ES (1) ES2073036T5 (de)
NL (1) NL8902301A (de)
WO (1) WO1991004330A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU631159B2 (en) * 1988-11-14 1992-11-19 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Parvovirus capsids
ATE332973T1 (de) * 1991-07-19 2006-08-15 Univ Queensland Polynukleotidabschnitt des hpv16-genoms
ES2048646B1 (es) * 1992-04-15 1994-10-01 Ercros Sa Procedimiento para la obtencion de la proteina vp2 del virus de la peste equina africana (ahsv)
US5437951A (en) 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
ATE188746T1 (de) * 1993-10-28 2000-01-15 Deutsches Krebsforsch Adeno-assozierter virus - dessen diagnostischen anwendung für frühe abtreibung
WO1996027799A1 (en) * 1995-03-08 1996-09-12 Klaus Hedman Method for the diagnosis of infections
ES2282998T3 (es) * 1996-01-02 2007-10-16 Institut Pasteur Pseudo-particularmente viricas recombinadas y aplicaciomnes vacunales y antitumorales.
FR2771751B1 (fr) 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6818612B2 (en) 1998-11-24 2004-11-16 Kristina Broliden Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
US6743772B1 (en) 1998-11-24 2004-06-01 Kristina Broliden Use of parovirus capsid particles in the inhibition of cell proliferation and migration
SE520177C2 (sv) * 1998-11-24 2003-06-03 Kristina Broliden Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller
CZ308201B6 (cs) 2001-06-28 2020-02-26 Grifols Worldwide Operations Limited Diagnostické zkoušky pro parvovirus B19
JP4734608B2 (ja) * 2004-07-01 2011-07-27 国立大学法人東京工業大学 生理的条件下でのウイルス粒子様構造体及びその形成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine

Also Published As

Publication number Publication date
NL8902301A (nl) 1991-04-02
DE69019359T2 (de) 1995-10-12
EP0491824B1 (de) 1995-05-10
DE69019359T3 (de) 2006-09-07
ATE122395T1 (de) 1995-05-15
ES2073036T3 (es) 1995-08-01
EP0491824A1 (de) 1992-07-01
WO1991004330A1 (en) 1991-04-04
DK0491824T4 (da) 2006-05-08
DK0491824T3 (da) 1995-07-17
ES2073036T5 (es) 2006-08-01
EP0491824B2 (de) 2006-04-12

Similar Documents

Publication Publication Date Title
DE69019359T2 (de) Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
WO2002032962A3 (en) Compositions of human proteins and method of use thereof
DE69731289D1 (de) Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
DE3886506T2 (de) Avirulente mikroben und deren verwendungen.
NO20012812L (no) Vaksinesammensetning og vaksine samt anvendelse av polypeptid og polynukletid
NO902802D0 (no) Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus.
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
ATE236980T1 (de) Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
ATE159170T1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
WO1996009391A3 (en) Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
ATE449173T1 (de) 32144, eine humane fettsäureamid-hydrolase und deren verwendungen
DE68923286T2 (de) Impfstoffe und testsätze für haemophilus influenzae.
ATE181104T1 (de) Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung
ATE480620T1 (de) Neue pgc-1-isoformen und deren verwendungen
ATE470716T1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
ATE476194T1 (de) Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür
DE60136832D1 (de) Atcr-1, eine humane acyltransferase und verwendungen davon
ATE435285T1 (de) 14189, eine humane kinase und deren verwendungen
WO2002002759A3 (en) A human alpha/beta hydrolase family member (32225) and uses thereof
WO2001075098A3 (en) 33166, a human hydrolase-like molecule and uses thereof
WO2002048330A3 (en) 21908 and 21911, human guanylate kinase family members and uses thereof

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings